E-ISSN 2231-3206 | ISSN 2320-4672
 
2024, Vol: 14, Issue: 4
14 / 4Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

Authorship Declaration

Original Research

Online Publishing Date:
22 / 08 / 2020

 


Serum potassium levels of patients on angiotensin converting enzyme inhibitors – A cross-sectional study

Vishnupriya Ramakrishnan, Suganeshwari Soundarapandian.


Abstract
Background: Angiotensin-converting enzyme (ACE) inhibitors are commonly used in clinical practice to treat hypertension. Hyperkalemia develops in approximately 10% of outpatients within a year of prescription of these drugs.

Aim and Objective: The aim of this study was to identify the prevalence of hyperkalemia among outpatients who are taking ACE inhibitors for hypertension for more than 6 months.

Materials and Methods: This was a cross-sectional study conducted in the Hypertension Clinic, Tirunelveli Medical College. Around 152 hypertensive patients taking ACE inhibitors for more than 6 months were enrolled in the study. Blood samples were obtained, and their serum potassium levels were measured.

Results: Among 152 patients, there were 88 male patients (57.9%) and 64 female patients (42.1%). Ten patients (35.71%) out of 18 patients who were on monotherapy presented with hyperkalemia and 20 patients (16.12%) out of 104 patients who were on combination therapy had hyperkalemia. A higher number of patients with hyperkalemia falls in the age group of 46–60 years of age. Out of 152 patients who took enalapril, 30 patients (19.73%) were found to have hyperkalemia. Of them, 20 patients (13.15%) had mild hyperkalemia, and ten patients (6.57%) had moderate hyperkalemia. There were no cases of severe hyperkalemia.

Conclusion: Hence, it is of considerable importance for physicians to identify patients at risk by regular monitoring and to implement measures to lessen the likelihood of the development of hyperkalemia.

Key words: Hyperkalemia; Hypertension; Angiotensin-converting enzyme inhibitors


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Vishnupriya Ramakrishnan
Articles by Suganeshwari Soundarapandian
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Ramakrishnan V, Soundarapandian S. Serum potassium levels of patients on angiotensin converting enzyme inhibitors – A cross-sectional study. Natl J Physiol Pharm Pharmacol. 2020; 10(12): 1076-1079. doi:10.5455/njppp.2020.10.07204202010082020

Web Style

Ramakrishnan V, Soundarapandian S. Serum potassium levels of patients on angiotensin converting enzyme inhibitors – A cross-sectional study. https://www.njppp.com/?mno=113123 [Access: March 14, 2024]. doi:10.5455/njppp.2020.10.07204202010082020

AMA (American Medical Association) Style

Ramakrishnan V, Soundarapandian S. Serum potassium levels of patients on angiotensin converting enzyme inhibitors – A cross-sectional study. Natl J Physiol Pharm Pharmacol. 2020; 10(12): 1076-1079. doi:10.5455/njppp.2020.10.07204202010082020


Vancouver/ICMJE Style

Ramakrishnan V, Soundarapandian S. Serum potassium levels of patients on angiotensin converting enzyme inhibitors – A cross-sectional study. Natl J Physiol Pharm Pharmacol. (2020), [cited March 14, 2024]; 10(12): 1076-1079. doi:10.5455/njppp.2020.10.07204202010082020


Harvard Style

Ramakrishnan, V. & Soundarapandian, . S. (2020) Serum potassium levels of patients on angiotensin converting enzyme inhibitors – A cross-sectional study. Natl J Physiol Pharm Pharmacol, 10 (12), 1076-1079. doi:10.5455/njppp.2020.10.07204202010082020


Turabian Style

Ramakrishnan, Vishnupriya, and Suganeshwari Soundarapandian. 2020. Serum potassium levels of patients on angiotensin converting enzyme inhibitors – A cross-sectional study. National Journal of Physiology, Pharmacy and Pharmacology, 10 (12), 1076-1079. doi:10.5455/njppp.2020.10.07204202010082020


Chicago Style

Ramakrishnan, Vishnupriya, and Suganeshwari Soundarapandian. "Serum potassium levels of patients on angiotensin converting enzyme inhibitors – A cross-sectional study." National Journal of Physiology, Pharmacy and Pharmacology 10 (2020), 1076-1079. doi:10.5455/njppp.2020.10.07204202010082020


MLA (The Modern Language Association) Style

Ramakrishnan, Vishnupriya, and Suganeshwari Soundarapandian. "Serum potassium levels of patients on angiotensin converting enzyme inhibitors – A cross-sectional study." National Journal of Physiology, Pharmacy and Pharmacology 10.12 (2020), 1076-1079. Print. doi:10.5455/njppp.2020.10.07204202010082020


APA (American Psychological Association) Style

Ramakrishnan, V. & Soundarapandian, . S. (2020) Serum potassium levels of patients on angiotensin converting enzyme inhibitors – A cross-sectional study. National Journal of Physiology, Pharmacy and Pharmacology, 10 (12), 1076-1079. doi:10.5455/njppp.2020.10.07204202010082020


Author LoginReviewer LoginAbout PublisherEditorial PoliciesEditorial Review PolicyPeer Review PolicyEditorial & Peer Review ProcessPublication Ethics and Publication Malpractice StatementConflict of Interest PolicyPlagiarism PolicyProtection of Research Participants (Statement On Human And Animal Rights)Corrections, Retractions & Expressions of ConcernSelf-Archiving PoliciesStatement of Informed ConsentAdvertising PolicyTerms of UseLicense InformationCopyright Information

About National Journal of Physiology, Pharmacy and Pharmacology

  National Journal of Physiology, Pharmacy and Pharmacology is a monthly peer reviewed journal.  The journal is having open access polic ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information


Publisher

publishernjppp@gmail.com

 

Editorial query

editornjppp1@gmail.com

MOB - 8780040272